G2 (Dual Agonist) (5mg)
$500.00
G2 is a dual-acting compound targeting both GLP-1 and GIP receptors. It is utilized in research to study the simultaneous stimulation of insulin-related pathways and the suppression of glucagon. Documentation focuses on its impact on glucose homeostasis and satiety signaling mechanisms.
Availability: In Stock
Description
Description
G2 (Dual Agonist)
5MG RESEARCH UNIT
TARGET: GLP-1 / GIP
CAS: Investigational
✓ PURITY VERIFIED ≥ 99%
| Unit Size | 5mg Lyophilized Powder |
|---|---|
| Mechanism Type | Dual Incretin Agonist |
| Research Focus | Glucose Homeostasis & Satiety Signaling |
| Biological Class | Dual Agonist Peptide |
Scientific Research Monographs // Educational Use Only
Synergistic Incretin Modulation
Scientific Findings
G2 is a co-agonist that targets the GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors. Research documentation focuses on its ability to stimulate insulin-related pathways while suppressing glucagon secretion. This dual activation is studied for its potent effects on glucose homeostasis and weight-related satiety mechanisms.
Plain English Interpretation
G2 acts on two separate biological pathways simultaneously. By hitting both the GLP-1 and GIP "switches," it helps the body manage sugar levels more effectively and sends stronger signals to the brain that it is full, making it a key focus for metabolic and satiety research.
Metabolic Refinement & Insulin Sensitivity
Scientific Findings
In laboratory settings, G2 is utilized to investigate the refinement of energy metabolism. Documentation highlights its impact on enhancing insulin sensitivity and its potential role in regulating lipid metabolism via dual-receptor occupancy, offering a broader research scope than single-agonist compounds.
Plain English Interpretation
Researchers use G2 to study how the body can be made more sensitive to its own insulin. Because it works through two different channels, it provides a more comprehensive look at how the body processes fats and sugars compared to older, single-target substances.
RESEARCH NOTICE: For laboratory research and development only. Not for human consumption. Reference: AP-G2-05-2026.
Reviews (0)
Storage Details
Stability & Storage Protocol
DOC ID: AP-STB-2026
Advanced Lyophilization Process
At Accel Peptides, we partner with manufacturing facilities specializing in Lyophilization (freeze-drying). This advanced process ensures compounds remain stable during transit and storage for over 12 months.When kept in their freeze-dried state, these compounds stay effective for extended periods. For long-term preservation, we recommend storing them in the freezer to maintain maximum molecular integrity.
FDA Standard Requirement
The common "discard 28 days after first use" guideline is a standard requirement set for multi-use vials to confirm bacteriostatic water retains its preservative qualities.
Accel Empirical Experience
With strict sterile handling and refrigeration, a reconstituted vial can safely remain stable and effective for three months or longer.
*Stability is dependent on sterile technique and consistent temperature control.
Certificates of Analysis
13 Peptide COAs
Avg purity —%
Lab: Freedom Diagnostics
| Peptide / Blend | Batch / Product Lot | Accession No. | Reported Date | Purity (HPLC-MS) | Laboratory | Certificate |
|---|
Related products
$149.00 — or Original price was: $149.00.$119.20Current price is: $119.20. / month
$279.00 — or Original price was: $279.00.$223.20Current price is: $223.20. / month
Reviews
There are no reviews yet.